Skip to main content
Fig. 11 | Journal of Nanobiotechnology

Fig. 11

From: A combination of a TLR7/8 agonist and an epigenetic inhibitor suppresses triple-negative breast cancer through triggering anti-tumor immune

Fig. 11

The correlation between the expression of CD11cCD86, TNF-α, and BRD4 in clinical specimens of TNBC. (a) Representative fluorescent images. II, III: Grade two, grade three. (+), (-): With or without lymph node metastasis. Blue: DAPI; green: CD11c; pink: CD86; red: TNF-α; orange: BRD4. (b) Mean fluorescence intensity of representative images and correlation with tumor grade. (c) Correlation analysis of CD11c, CD86, TNF-α and BRD4 expression. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us